Europe — EMA
Onbrez Breezhaler (Indacaterol)
Indacaterol, the active ingredient in Onbrez Breezhaler, is a bronchodilator presented as a inhalation powder for oral inhalation use.
Request sourcing
What is Indacaterol?
Indacaterol, the active ingredient in Onbrez Breezhaler, is a bronchodilator presented as a inhalation powder for oral inhalation use. It provides long‑acting bronchodilation for patients with chronic obstructive pulmonary disease (COPD). GNH USA supplies Onbrez Breezhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
GNH USA supplies Onbrez Breezhaler as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Indacaterol used for?
Onbrez Breezhaler is a long‑acting bronchodilator indicated for chronic obstructive pulmonary disease management. It helps maintain airway openness and reduce symptom variability. - COPD: Improves lung function and reduces exacerbation risk. - Chronic bronchitis: Provides sustained bronchodilation to ease breathing. - Emphysema: Helps keep airways open, supporting better airflow.
What are the side effects of Indacaterol?
Adverse reactions to inhaled indacaterol are generally mild to moderate and reflect its pharmacologic activity in the respiratory tract.
Common Side Effects: - Cough - Throat irritation - Nasal congestion - Headache - Upper respiratory tract infection - Dry mouth
Serious or Rare Side Effects: - Paradoxical bronchospasm - Cardiovascular events such as tachycardia - Severe allergic reactions (anaphylaxis) - Hypersensitivity pneumonitis - Persistent wheezing - Acute respiratory failure
What precautions apply to Indacaterol?
When using Onbrez Breezhaler, patients should follow the prescribed inhalation technique and monitor their response. - Assess suitability: Verify "); - Assess "); "); \
